AGF Investments LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
AGF Investments LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$1,755,000
+28.7%
8,970
+11.8%
0.20%
+41.0%
Q2 2020$1,364,000
+16950.0%
8,026
+11531.9%
0.14%
+13800.0%
Q1 2020$8,000
-20.0%
69
-62.1%
0.00%
-50.0%
Q2 2017$10,0000.0%182
+26.4%
0.00%
-33.3%
Q1 2017$10,0000.0%144
-23.4%
0.00%0.0%
Q4 2016$10,0001880.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,049,760$3,738,884,00023.93%
Lagoda Investment Management, L.P. 76,873$5,630,0007.16%
Matrix Capital Management Company, LP 3,141,852$230,109,0006.14%
DOMINI IMPACT INVESTMENTS LLC 3,120$229,0003.51%
Opus Point Partners Management, LLC 17,832$1,306,0001.77%
Capital International Sarl 188,200$13,784,0001.72%
EMORY UNIVERSITY 33,368$2,444,0001.72%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,900$4,460,0001.65%
CAPITAL GUARDIAN TRUST CO 1,358,254$99,415,0001.32%
Rhenman & Partners Asset Management AB 150,598$11,030,0001.29%
View complete list of SEATTLE GENETICS INC shareholders